Related Experiment Videos
Level of macrophage induction during tumor growth: primed or activated?
Abstract:
The activation level of thioglycolate (TG)-elicited peritoneal macrophages (Mphi) from normal and fibrosarcoma-bearing BALB/c mice was investigated. Lipopolysaccharide was used to distinguish in vitro levels of Mphi activation. The results of cytotoxicity assays, which measured nonspecific killing of P815 tumor cells by activated Mphi, indicated that tumor-bearing host Mphi were primed in situ while normal host Mphi remained in a resting state. This level of Mphi induction may contribute to the resulting tumor-bearing host T cell immune hyporesponsiveness.
Insights
Peritoneal macrophages (Mphi) from tumor-bearing mice show higher activation levels compared to normal mice. This heightened Mphi induction may lead to T cell immune hyporesponsiveness in tumor hosts.
Area of Science:
- Immunology
- Cancer Biology
Background:
- Macrophages play a crucial role in immune responses and cancer progression.
- Tumor microenvironments can modulate macrophage function.
Purpose of the Study:
- To investigate the activation status of peritoneal macrophages in fibrosarcoma-bearing mice.
- To compare macrophage activation in tumor-bearing hosts versus normal hosts.
Main Methods:
- Thioglycolate-elicited peritoneal macrophages were isolated from normal and fibrosarcoma-bearing BALB/c mice.
- Lipopolysaccharide was used to assess in vitro macrophage activation levels.
- Cytotoxicity assays measured the killing of P815 tumor cells by activated macrophages.
Main Results:
- Macrophages from tumor-bearing mice were found to be primed in situ.
- Macrophages from normal mice remained in a resting state.
- Activated macrophages demonstrated non-specific killing of tumor cells.
Conclusions:
- Tumor-bearing host macrophages exhibit an activated phenotype.
- This macrophage activation may contribute to T cell immune hyporesponsiveness in cancer patients.